FY26 Reference Laboratory Testing Services (Request for Information)
ID: PANHCA25P0000006383Type: Special Notice
Overview

Buyer

DEPT OF DEFENSEDEPT OF THE ARMYW40M USA HCAJBSA FT SAM HOUSTON, TX, 78234-5074, USA

Original Source

https://sam.gov/opp/8f336e443c7c4cc78cff0c7334a2fcf2/view
Timeline
    Description

    The Department of Defense, specifically the Department of the Army, is seeking information regarding the procurement of clinical reference laboratory testing services for fiscal year 2026. The contractor will provide non-personal services to support U.S. military and health agencies, ensuring compliance with quality standards set by the Clinical Laboratory Improvement Amendments (CLIA) and the College of American Pathologists (CAP). These services are critical for conducting specialized and high-cost tests that are not feasible for government in-house capabilities, covering various medical disciplines such as microbiology and molecular testing. Interested parties can direct inquiries to Jimika Drake at jimika.a.drake.civ@mail.mil or David D. Robledo at david.d.robledo.civ@health.mil, with further details outlined in the Performance Work Statement and associated documentation.

    Point(s) of Contact
    Jimika Drake
    (210) 221-4975
    jimika.a.drake.civ@mail.mil
    David D. Robledo
    (210) 221-5490
    (210) 221-5402
    david.d.robledo.civ@health.mil
    Files
    Title
    Posted
    1 Year Estimate Exhibit C Schedule of Required Tests.xlsx
    The document outlines the Clinical Reference Laboratory Testing Services required under RFP W81K04-20-R-0017. It details a comprehensive schedule of tests necessary for potential offers, categorized by Current Procedural Terminology (CPT) codes and associated fees. Each entry includes the test name, testing methodology, estimated yearly quantity, and provider information where applicable. The range of tests encompasses various medical fields, including drug screening, metabolic profiles, genetic testing, and immunological assays. This structured approach highlights the government's need for standardized laboratory testing crucial for healthcare services, emphasizing compliance with federal requirements for quality and accuracy in medical diagnostics. Overall, this RFP serves to solicit proposals from laboratories capable of meeting these diverse testing needs, ensuring thorough service provision and maintaining public health standards.
    Reference Lab PWS 6 Feb 25 RFI.docx
    The Performance Work Statement (PWS) outlines a non-personal services contract for clinical reference laboratory testing services to support U.S. military and health agencies. The contractor will not be supervised by the government but must comply with quality standards set forth by the Clinical Laboratory Improvement Amendments (CLIA) and the College of American Pathologists (CAP). Services include specialized, high-cost tests not feasible for government in-house capabilities, supporting diverse disciplines such as microbiology and molecular testing. Key objectives require the contractor to ensure timely processing and reporting of tests using their Laboratory Information System (LIS) integrated with Military Health System (MHS) Genesis. A comprehensive Quality Control Plan (QCP) must be maintained, emphasizing accuracy and ongoing compliance. The contractor must facilitate a six-month transition period upon contract award to ensure readiness, maintain essential certifications, and comply with security and background checks for personnel. Additional provisions cover operational hours, communication protocols, personnel requirements, and safety guidelines. The document serves as a blueprint for ensuring effective laboratory testing support within regulatory frameworks and security measures, critical for optimal operational efficiency in military medical environments.
    Lifecycle
    Title
    Type
    FY26 Reference Laboratory Testing Services (Request for Information)
    Currently viewing
    Special Notice
    Similar Opportunities
    Clinical Reference Laboratory Testing Services at Brian D. Allgood Army Community Hospital (BDAACH), South Korea
    Buyer not available
    The Department of Defense is seeking qualified vendors to provide Clinical Reference Laboratory Testing Services at the Brian D. Allgood Army Community Hospital (BDAACH) in South Korea. The procurement aims to secure comprehensive medical laboratory testing services that are critical for patient care and operational readiness within the military healthcare system. These services will support the hospital's mission by ensuring timely and accurate laboratory results, which are essential for diagnosis and treatment. Interested parties can reach out to Scott Saito at scott.k.saito.civ@health.mil or call 808-433-9512 for further information regarding this presolicitation opportunity.
    Microbiological Identification/Susceptibility (ID/AST) testing support for the Landstuhl Regional Medical Center (LRMC), Germany
    Buyer not available
    The Department of Defense, through the Department of the Army, is seeking contractors to provide microbiological identification and susceptibility testing support for the Landstuhl Regional Medical Center (LRMC) in Germany. The procurement involves a five-year contract for the delivery, installation, maintenance, and repair of an Organism Sensitivity and Identification System, along with necessary reagents and supplies, adhering to Clinical Laboratory Improvement Amendments guidelines. This testing support is crucial for ensuring accurate diagnostics and effective treatment protocols within military medical facilities. Interested contractors should contact Henning Mayer-Goldstein at henningfalk.mayer-goldstein.ln@health.mil or Matthew R. Elden at matthew.r.elden.civ@health.mil for further details, and must comply with the submission requirements outlined in the solicitation documents, with deadlines specified in the amendment.
    Q301--36C26125Q0190 | Reference Lab Testing Services
    Buyer not available
    The Department of Veterans Affairs (VA) is seeking qualified contractors to provide comprehensive Reference Laboratory Testing Services for the Sacramento VA Medical Center. The procurement aims to secure a contractor responsible for specimen preparation, transportation, analytical testing, and reporting results, while ensuring compliance with regulatory standards and maintaining a valid chain of custody for clinical specimens. This opportunity is particularly significant as it supports the VA's commitment to delivering high-quality healthcare services to veterans, with a contract period spanning from April 2025 to March 2029. Interested small businesses, especially Service-Disabled Veteran-Owned and Veteran-Owned entities, must submit their responses, including capability statements and relevant certifications, by February 24, 2025. For further inquiries, potential contractors can contact LaDonna Collins at ladonna.collins@va.gov.
    Q301--Biodesix, Inc. (621 II) (PENDING PROPOSAL)
    Buyer not available
    The Department of Veterans Affairs is soliciting proposals for reference laboratory services under the Federal Supply Schedule (FSS) program, specifically for medical laboratory testing related to disease diagnosis and patient health assessment. The procurement aims to establish contracts for services that comply with federal, state, and local regulations, including necessary licensing and accreditation, while ensuring that only new items are provided and that grey market goods are strictly prohibited. This opportunity is critical for enhancing the quality of healthcare services provided to veterans, with a focus on compliance with the Trade Agreements Act and other regulatory requirements. Interested vendors should contact Contract Specialist Brian O'Connell at Brian.O'connell@va.gov for further details, and they must adhere to the submission deadlines outlined in the solicitation documents.
    Q301 Reference Laboratory Testing for Spokane VA Medical Center
    Buyer not available
    The Department of Veterans Affairs is seeking qualified contractors to provide reference laboratory testing services for the Spokane VA Medical Center. The procurement aims to secure comprehensive laboratory services, including preanalytic processing, analysis, reporting, and interpretation of clinical results, adhering to federal, state, and local regulations. This initiative is crucial for enhancing healthcare delivery to veterans, ensuring timely and accurate testing while maintaining compliance with standards such as CLIA and those from the College of American Pathologists. Interested parties must respond by February 14, 2025, with their qualifications and relevant documentation, as the contract is expected to span from May 1, 2025, to April 30, 2030. For further inquiries, contact Eric Lingenfelter at eric.lingenfelter@va.gov or call 360-852-9891.
    6550--Lab Testing Services - (HIV/HCV/HPV/On)
    Buyer not available
    The Department of Veterans Affairs is seeking to negotiate a sole-source contract with Roche Diagnostics Corporation for lab testing services related to HIV, HCV, and HPV at the Corporal Michael J. Crescenz VA Medical Center. The contractor will be responsible for providing FDA-approved laboratory systems, instruments, maintenance, and consumables necessary for clinical testing, including a fully automated PCR testing platform with advanced features for real-time detection and minimal maintenance. This procurement is crucial for ensuring the delivery of quality healthcare services to veterans through efficient laboratory solutions. Interested parties must express their interest or submit capabilities by February 13, 2025, and can contact Contract Specialist Yazmin Alvarez at yazmin.alvarez@va.gov or 302-944-2511 x5202 for further information.
    6640--FY25 Q3 Micro Molecular Testing (VA-25-00029953)
    Buyer not available
    The Department of Veterans Affairs (VA) is soliciting offers for the procurement of micro molecular testing supplies under the reference number 36C24825Q0395. This opportunity includes a range of laboratory supplies and services, specifically diagnostic kits and laboratory equipment, with detailed specifications regarding quantities and unit prices. The procurement is crucial for enhancing healthcare services for veterans, ensuring the availability of essential medical testing supplies that meet quality standards. Interested vendors should note that the offer due date is March 12, 2025, and are encouraged to submit their proposals electronically, with the contract being open to various small business categories, including HUBZone and Service-Disabled Veteran-Owned businesses. For further inquiries, potential bidders can contact Contract Specialist David G Henry at David.Henry3@va.gov.
    Q301--Lab Testing Services - Mycobacteria Testing / Off Site
    Buyer not available
    The Department of Veterans Affairs is seeking potential sources for a three-year contract to provide mycobacteriology laboratory testing services, specifically focusing on nontuberculous and drug-resistant tuberculosis testing. The procurement requires laboratory capabilities that include molecular and growth detection, isolate identification, and antimicrobial susceptibility testing for various mycobacterial strains. This initiative is crucial for ensuring effective diagnosis and treatment of mycobacterial infections among veterans. Interested parties must be registered in the System for Award Management (SAM) and are encouraged to verify their status as Service-Disabled Veteran-Owned or Veteran-Owned Small Businesses in the VetBiz Registry. Responses, including a capability statement and specific business information, are due by February 14, 2025, at 12:00 PM EST. For further inquiries, interested vendors can contact Contracting Officer Victoria Droz at Victoria.Droz@va.gov or by phone at 412-822-3754.
    Notice of Intent to Sole Source to Extend Services for N6264520P0020 - Molecular Assay-Analyzers
    Buyer not available
    The Department of Defense, through the Defense Health Agency (DHA), intends to issue a sole source bridge contract to BioFire Defense, LLC for the provision of a molecular diagnostic laboratory analyzer, along with necessary assays, reagents, and consumables at Naval Hospital Camp Pendleton and Naval Medical Center Portsmouth. The contract, which is set to run from April 16, 2025, to October 15, 2025, with an option for an additional six months, requires the analyzer to perform a variety of tests using polymerase chain reaction (PCR) technology, including respiratory, blood culture, gastrointestinal, and meningitis/encephalitis assays, while ensuring compliance with FDA regulations. This procurement is critical for maintaining effective diagnostic capabilities within military medical facilities, and interested vendors must submit capability statements by February 28, 2025, as the procurement will not be open for competitive proposals. For further inquiries, vendors can contact Margaret Suever at margaret.a.suever.civ@health.mil or by phone at 210-952-8283.
    OCONUS Hematology Support
    Buyer not available
    The Department of Defense, specifically the Department of the Army, is seeking proposals for OCONUS Hematology Support under a Combined Synopsis/Solicitation notice. The procurement involves providing automated hematology analyzers, reagents, maintenance, and training across multiple U.S. Army Medical facilities in Europe, operating on a Cost Per Reportable Result (CPRR) basis. This initiative is crucial for enhancing clinical capabilities and ensuring high-quality healthcare services for military personnel, with a contract period from May 1, 2025, to September 30, 2029. Interested vendors should note that the contract will be awarded on March 1, 2025, and are encouraged to contact Henning Mayer-Goldstein at henningfalk.mayer-goldstein.ln@health.mil or Matthew R. Elden at matthew.r.elden.civ@health.mil for further details.